Latest Articles
Study Explores Link Between Irisin Hormone Levels and Endometrial Cancer Progression - geneonline.com
Study Explores Link Between Irisin Hormone Levels and Endometrial Cancer Progression geneonline.com
Published: Oct. 1, 2025, 12:08 a.m.
Gesynta Pharma receives UK approval for a Phase 2 trial of vipoglanstat in endometriosis - beQuoted
Gesynta Pharma receives UK approval for a Phase 2 trial of vipoglanstat in endometriosis beQuoted
Published: Sept. 30, 2025, 8 a.m.
'Severe period pain – it's not normal' - Yahoo News Canada
'Severe period pain – it's not normal' Yahoo News Canada
Published: Sept. 30, 2025, 6:05 a.m.
Genescience Pharmaceuticals divulges new 17β-HSD1 inhibitors - BioWorld MedTech
Genescience Pharmaceuticals divulges new 17β-HSD1 inhibitors BioWorld MedTech
Published: Sept. 29, 2025, 1 p.m.
I was in constant pain for a decade but everyone told me it was normal - Liverpool Echo
I was in constant pain for a decade but everyone told me it was normal Liverpool Echo
Published: Sept. 29, 2025, 4 a.m.
Depo Provera Lawsuit Settlement | Sept 2025 Litigation Update - Lawsuit Information Center
Depo Provera Lawsuit Settlement | Sept 2025 Litigation Update Lawsuit Information Center
Published: Sept. 26, 2025, 5:53 p.m.
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug By Investing.com - Investing.com Australia
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug By Investing.com Investing.com Australia
Published: Sept. 26, 2025, 11:03 a.m.
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug By Investing.com - Investing.com South Africa
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug By Investing.com Investing.com South Africa
Published: Sept. 26, 2025, 10:56 a.m.
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug - Investing.com India
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug Investing.com India
Published: Sept. 26, 2025, 10:48 a.m.
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug - Investing.com
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug Investing.com
Published: Sept. 26, 2025, 10:25 a.m.
Link copied to clipboard!